EUVIMEDEUVIMED entdecken
Open Access

Radiotherapy beam tracking by dual-modality injectable fiducial marker for X-ray CT and Cherenkov luminescence imaging

Xu Cao iD, Matthew S Reed, Wesley S Culberson, Brian W Pogue iD

Biomedical Optics Express · 01.07.2026 · 17 (7) · 3449

DOI: 10.1364/boe.597050 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Optics Express, online erschienen am 04.06.2026. Verfasst von Xu Cao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Physics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison WI, 53705, USA. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIBIB NIH HHS, NIH HHS.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accurate beam targeting is critical in radiation therapy, particularly for stereotactic treatments of mobile organs where fiducial markers are routinely used for image guidance. However, current approaches do not provide real-time confirmation that the therapeutic radiation beam is accurately delivered to the intended target during irradiation. This study presents a preliminary proof-of-concept evaluation of a dual-modality fiducial marker that combines a liquid injectable fiducial material for X-ray computed tomography (CT) contrast with a biocompatible radioluminescent ink, enabling both pre-treatment localization and intra-treatment optical verification. The proposed formulation can be delivered by syringe into anatomical sites and readily visualized on CT for treatment planning and alignment. During irradiation, Cherenkov light generated within tissue excites the marker, producing visible luminescence detectable with a time-gated imaging system and enabling Cherenkov-excited luminescence imaging (CELI) of beam position in real time. Phantom studies demonstrated detection sensitivity for injected volumes as small as 20 µL and radiation doses as low as 2.8 cGy, with measurable signals at depths up to 8 mm in tissue-mimicking media. The liquid fiducial provided clear CT visualization of the injection site prior to treatment, while CELI enabled real-time visualization of the radiation beam during irradiation in vivo. A strong spatial correlation was observed between emitted luminescence and radiation beam location. These results demonstrate the feasibility of a simple subcutaneous injectable fiducial marker system for real-time beam verification in radiation therapy using clinically Cherenkov imaging cameras.

Autor:innen und Institutionen

  • Department of Medical Physics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison WI, 53705, USA.
  • Thayer School of Engineering at Dartmouth, Hanover, NH, 03755, USA.
  • School of Life Science and Technology, Xidian University, Xi'an, Shaanxi, China.
  • Xu.Cao@dartmouth.edu.
  • brian.w.pogue@dartmouth.edu.

ORCID-Profile: Xu Cao, Brian W Pogue

Förderung

  • NCI NIH HHS
  • NIBIB NIH HHS
  • NIH HHS
  • UW Carbone Cancer Center
  • National Institutes of Health

Zitieren

APA

Cao, X., Reed, M. S., Culberson, W. S., & Pogue, B. W. (2026). Radiotherapy beam tracking by dual-modality injectable fiducial marker for X-ray CT and Cherenkov luminescence imaging. Biomedical Optics Express, 17(7), 3449. https://doi.org/10.1364/boe.597050

Vancouver

Cao X, Reed MS, Culberson WS, Pogue BW. Radiotherapy beam tracking by dual-modality injectable fiducial marker for X-ray CT and Cherenkov luminescence imaging. Biomedical Optics Express. 2026;17(7):3449. doi:10.1364/boe.597050

BibTeX
@article{Cao2026,
  author = {Cao, Xu and Reed, Matthew S and Culberson, Wesley S and Pogue, Brian W},
  title = {Radiotherapy beam tracking by dual-modality injectable fiducial marker for X-ray CT and Cherenkov luminescence imaging},
  journal = {Biomedical Optics Express},
  year = {2026},
  volume = {17},
  number = {7},
  pages = {3449},
  doi = {10.1364/boe.597050}
}
Kostenlos starten →